Publications by authors named "Daniel Croker"

Claim this Profile
C
Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling.
Zoe V Schofield, Daniel Croker, Avril A B Robertson, Nicholas L Massey, Chantal Donovan

Sci Rep· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950.
Manohar Salla, Mark S Butler, Ruby Pelingon, Geraldine Kaeslin, Daniel E Croker

ACS Med Chem Lett· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.
Daniel E Croker, Peter N Monk, Reena Halai, Geraldine Kaeslin, Zoe Schofield

Immunol Cell Biol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties.
Andreas Brust, Daniel E Croker, Barbara Colless, Lotten Ragnarsson, Åsa Andersson

J Med Chem· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Rebecca C Coll, Avril A B Robertson, Jae Jin Chae, Sarah C Higgins, Raúl Muñoz-Planillo, Daniel E Croker

Nat Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation of ligands for the complement C3a receptor from the C-terminus of C5a.
Reena Halai, Meghan L Bellows-Peterson, Will Branchett, James Smadbeck, Chris A Kieslich, Daniel E Croker

Eur J Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitment.
Daniel E Croker, Reena Halai, Geraldine Kaeslin, Elisabeth Wende, Beate Fehlhaber

Immunol Cell Biol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2.
Daniel E Croker, Reena Halai, David P Fairlie, Matthew A Cooper

Immunol Cell Biol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling.
Reena Halai, Daniel E Croker, Jacky Y Suen, David P Fairlie, Matthew A Cooper

Biosensors (Basel)· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.
Andreas Brust, Elka Palant, Daniel E Croker, Barbara Colless, Roger Drinkwater

J Med Chem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides.
Sébastien Dutertre, Daniel Croker, Norelle L Daly, Asa Andersson, Markus Muttenthaler

J Biol Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric alpha 1-adrenoreceptor antagonism by the conopeptide rho-TIA.
Iain A Sharpe, Linda Thomas, Marion Loughnan, Leonid Motin, Elka Palant, Daniel E Croker

J Biol Chem· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis